Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorcas Beaton

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
The Journal of Rheumatology|December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical TrialsAna-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
The Journal of Rheumatology|February 17, 2019
Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop ReportAlí Duarte-García, Ying Ying Leung, Laura C Coates, et al.
The Patient|October 6, 2016
Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)Maarten de Wit, John R Kirwan, Peter Tugwell, et al.
Seminars in Arthritis and Rheumatism|September 8, 2021
Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 processDavid Roofeh, Shaney L Barratt, Athol U Wells, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working groupKen Cai, Amy Fuller, Yiling Zhang, et al.
Annals of the Rheumatic Diseases|April 9, 2021
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritisAnnelies Boonen, Polina Putrik, Mary Lucy Marques, et al.
Journal of Clinical Epidemiology|June 7, 2024
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Ellen B M Elsman, Lidwine B Mokkink, Caroline B Terwee, et al.
Journal of Patient-Reported Outcomes|July 8, 2024
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Ellen B M Elsman, Lidwine B Mokkink, Caroline B Terwee, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
The Journal of Rheumatology|December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical TrialsAna-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
The Journal of Rheumatology|February 17, 2019
Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop ReportAlí Duarte-García, Ying Ying Leung, Laura C Coates, et al.
The Patient|October 6, 2016
Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)Maarten de Wit, John R Kirwan, Peter Tugwell, et al.
Seminars in Arthritis and Rheumatism|September 8, 2021
Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 processDavid Roofeh, Shaney L Barratt, Athol U Wells, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working groupKen Cai, Amy Fuller, Yiling Zhang, et al.
Annals of the Rheumatic Diseases|April 9, 2021
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritisAnnelies Boonen, Polina Putrik, Mary Lucy Marques, et al.
Journal of Clinical Epidemiology|June 7, 2024
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Ellen B M Elsman, Lidwine B Mokkink, Caroline B Terwee, et al.
Journal of Patient-Reported Outcomes|July 8, 2024
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Ellen B M Elsman, Lidwine B Mokkink, Caroline B Terwee, et al.
Pageof 13